| 5 mins | 30 mins | Hourly | Daily | Weekly |
|---|---|---|---|---|
| BUY | BUY | BUY | BUY | SELL |
| 5 mins | 30 mins | Hourly | Daily | Weekly | |
|---|---|---|---|---|---|
| MA5 | 3.53▲ | 3.51▲ | 3.50▲ | 3.17▲ | 2.62▲ |
| MA10 | 3.52▲ | 3.50▲ | 3.43▲ | 2.97▲ | 2.97▲ |
| MA20 | 3.51▲ | 3.40▲ | 3.29▲ | 2.58▲ | 3.90▼ |
| MA50 | 3.50▲ | 3.19▲ | 3.08▲ | 3.06▲ | 6.03▼ |
| MA100 | 3.43▲ | 3.05▲ | 2.73▲ | 4.14▼ | 6.18▼ |
| MA200 | 3.29▲ | 2.69▲ | 2.70▲ | 5.92▼ | 6.55▼ |
| 5 mins | 30 mins | Hourly | Daily | Weekly | |
|---|---|---|---|---|---|
| MACD | 0.004▲ | 0.001▲ | 0.021▲ | 0.158▲ | 0.018▲ |
| RSI | 65.044▲ | 74.870▲ | 77.353▲ | 67.429▲ | 42.791▼ |
| STOCH | 73.027 | 78.359 | 88.327▲ | 90.764▲ | 28.777 |
| WILL %R | -15.789▲ | -5.085▲ | -2.804▲ | -1.299▲ | -41.552 |
| CCI | 180.000▲ | 156.520▲ | 93.952 | 143.543▲ | -5.079 |
|
Wednesday, April 30, 2025 01:05 PM
Terns Pharmaceuticals, Inc. (“Terns” or the “Company”) (Nasdaq: TERN), a clinical-stage biopharmaceutical company developing a portfolio of small-molecule product candidates to address serious ...
|
|
Tuesday, April 29, 2025 12:26 PM
Viking Therapeutics (NASDAQ:VKTX) and other developers of oral weight loss drugs traded sharply higher on Tuesday after Pfizer (NYSE:PFE) CEO Albert Bourla indicated plans to seek deals to add ...
|
|
Tuesday, April 29, 2025 12:26 PM
Viking Therapeutics (NASDAQ:VKTX) and other developers of oral weight loss drugs traded sharply higher on Tuesday after Pfizer (NYSE:PFE) CEO Albert Bourla indicated plans to seek deals to add ...
|
| date | open | high | low | close | volume |
|---|---|---|---|---|---|
| 01/05/25 | 3.32 | 3.58 | 3.315 | 3.56 | 1,236,537 |
| 30/04/25 | 3.06 | 3.315 | 3.035 | 3.30 | 1,023,443 |
| 29/04/25 | 2.875 | 3.23 | 2.855 | 3.12 | 1,018,779 |
| 28/04/25 | 2.91 | 3.06 | 2.87 | 2.94 | 507,957 |
| 25/04/25 | 3.02 | 3.06 | 2.84 | 2.92 | 804,425 |
| 24/04/25 | 2.88 | 3.10 | 2.8115 | 3.05 | 1,108,720 |
| 23/04/25 | 2.86 | 3.06 | 2.8511 | 2.88 | 932,102 |
| 22/04/25 | 2.77 | 2.845 | 2.665 | 2.80 | 1,656,237 |
| 21/04/25 | 2.37 | 2.88 | 2.37 | 2.71 | 1,735,315 |
| 17/04/25 | 2.23 | 2.44 | 2.23 | 2.40 | 891,657 |
|
|
||||
|
|
||||
|
|